Methamphetamine (MIETH) is a highly addictive drug of abuse that has also raised concern since in laboratory animals it is neurotoxic to dopamine (DA) terminals. Moreover, recent imaging and postmortem studies in MIETH abusers have documented marked reductions in DA transporters (DAT), which serve as markers of DA terminals. However, the extent to which the DAT reductions in METH abusers are associated with abnormal DA cell function, the extent to which these changes may recover with detoxification and the extent to which they contribute to the addictive process have not been evaluated. In this competitive renewal we propose to assess whether the DAT losses in METH abusers are associated with disrupted DA cell function and to assess if they recover with detoxification. We will use positron emission tomography (PET) to measure DAT using 'C]cocaine (DAT radioligand) and to assess DA cell function by comparing the binding of raclopride (DA D2 radioligand whose binding to D2 receptors is sensitive to competition by endogenous DA) with and without pretreatment with methyiphenidate (drug that increases DA by blocking DAT). We propose to test METH abusers (n = 40) during early withdrawal (greater than 2 weeks and less than 3 months), and retest them 6-9 months later after a drug free period (we expect 10 abusers to return for testing). Normal controls (n = 20) will be tested in parallel and 10 of them will be retested 6-9 months later to assess reproducibility. Our working hypotheses are: ? ? (1) MIETH abusers will have decreased function of DA cells in addition to the loss of DAT (2) Detoxification will result in increase in DA cell function and in DAT levels. ? ? It is important to assess if there is disrupted DA cell function in METH abusers since it could perpetuate METH use as a means to temporarily compensate for this dysfunction. It is also of relevance to determine if it recovers with detoxification in order to understand the long-term consequences of DAT losses in the METH abusers vis a vis their vulnerability to neurodegenerative diseases (i.e Parkinson's disease). Such knowledge should help guide the management of the METH abuser and the development of medications that may help ameliorate the DA deficits.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA006891-14S1
Application #
7275235
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Grant, Steven J
Project Start
1990-09-30
Project End
2008-06-30
Budget Start
2005-07-01
Budget End
2008-06-30
Support Year
14
Fiscal Year
2006
Total Cost
$9,990
Indirect Cost
Name
Brookhaven National Laboratory
Department
Type
DUNS #
027579460
City
Upton
State
NY
Country
United States
Zip Code
11973
Wiers, C E; Towb, P C; Hodgkinson, C A et al. (2018) Association of genetic ancestry with striatal dopamine D2/D3 receptor availability. Mol Psychiatry 23:1711-1716
Wiers, Corinde E; Shokri-Kojori, Ehsan; Cabrera, Elizabeth et al. (2016) Socioeconomic status is associated with striatal dopamine D2/D3 receptors in healthy volunteers but not in cocaine abusers. Neurosci Lett 617:27-31
Wang, Gene-Jack; Geliebter, Allan; Volkow, Nora D et al. (2011) Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity (Silver Spring) 19:1601-8
Wang, Gene-Jack; Volkow, Nora D; Thanos, Panayotis K et al. (2009) Imaging of brain dopamine pathways: implications for understanding obesity. J Addict Med 3:8-18
Wang, Gene-Jack; Volkow, Nora D; Telang, Frank et al. (2009) Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci U S A 106:1249-54
Tomasi, Dardo; Wang, Gene-Jack; Wang, Ruiliang et al. (2009) Association of body mass and brain activation during gastric distention: implications for obesity. PLoS One 4:e6847
Tomer, Rachel; Goldstein, Rita Z; Wang, Gene-Jack et al. (2008) Incentive motivation is associated with striatal dopamine asymmetry. Biol Psychol 77:98-101
Volkow, Nora D; Ma, Yeming; Zhu, Wei et al. (2008) Moderate doses of alcohol disrupt the functional organization of the human brain. Psychiatry Res 162:205-13
Goldstein, Rita Z; Alia-Klein, Nelly; Tomasi, Dardo et al. (2007) Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? Am J Psychiatry 164:43-51
Volkow, Nora D; Fowler, Joanna S; Wang, Gene-Jack et al. (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64:1575-9

Showing the most recent 10 out of 78 publications